Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.


Genetic and Rare Diseases Information Center (GARD)

Print friendly version

Adenosarcoma of the uterus

Other Names for this Disease
  • Mullerian adenosarcoma of the uterus
  • Uterine adenosarcoma
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.

Your Question

Is radiation and/or chemotherapy considered appropriate if uterine adenosarcoma shows signs of spreading to the lymph node? Is ifosfamid an appropriate treatment? Is it available as an oral medication?

Our Answer

We have identified the following information that we hope you find helpful. If you still have questions, please contact us.

Is radiation and/or chemotherapy used to treat adenosarcoma of the uterus?

The recommended treatment option for adenosarcoma of the uterus is surgery. Total hysterectomy with bilateral salpingo-oophorectomy can cure this condition if it is only in the uterus. Adjuvant radiation therapy can help lower the chance of the tumor coming back. There is limited data and no agreement regarding the benefit of adjuvant chemotherapy. Chemotherapy or whole abdomen radiation therapy is used for disease that has spread into the intraperitoneal region. The chemotherapy agents consist of either doxorubicin or a combination of cisplatin and ifosfamide with mesna.[1] Ifosfamide is not available in an oral form; it is given by injection into a vein.
Last updated: 3/22/2013

  • Mirna Farha, Elie Hobeika, Ghada Moumneh and Anwar Nassar. Uterine mullerian adenosarcoma with sarcomatous overgrowth fatal recurrence within two weeks of diagnosis: a case report. Journal of Medical Case Reports. 2007; 1:103. Accessed 3/22/2013.